References to EU regulation or EU websites in our guidance will not be an accurate description of your obligations or rights under UK law.read more
Oxybutynin MR (Lyrinel XL)
It is not acceptable for short-term use prior to bladder
surgery. Only the sustained-release formulation is permitted.
Tolterodine MR (Detrusitol XL)
Trospium IR and MR (Regurin)
Side-effects to enquire about are mainly anti-cholinergic
such as dry mouth, blurred vision and drowsiness. If these do not occur in the
first few months they are extremely unlikely to occur later.
Unfit for a minimum of four weeks or until a stable dose is
achieved with adequate symptom control.
OML for at least four months.
If the dose of drug remains stable with satisfactory symptom
control and no reported side-effects, then unrestricted certification can be
considered at four months. Any change in dosage should entail a grounding
period of four weeks followed by reassessment. Pilots should be advised to keep
themselves hydrated before and during flights.
Unfit for a minimum of four weeks or until a stable dose to
achieve with adequate symptom control. If the dose of drug remains stable with
satisfactory symptom control and no reported side-effects, then unrestricted
certification can be considered at four weeks. Any change in dosage should
entail a grounding period of four weeks, followed by reassessment.
Read all @UK_CAA
Additional funding for electronic conspicuity devices announced
26 February, 2021
CAA launch Virtual Voyage 2021 General Aviation Summit
26 February, 2021
Civil Aviation Authority Transport Act 2000 investigation – final decision
25 February, 2021
Read all News
International Women’s Day 2021
8 March, 2021
National Apprenticeship Week 2021
8 February, 2021
International Civil Aviation Day
7 December, 2020
Read All Blogs